LivaNova PLC and MicroPort Scientific Corporation today announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management Co. Ltd. obtained approval for its family of RegaTM pacemakers from the China Food and Drug Administration.
